Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Barrett's esophagus. --- Esophagus --- Abnormalities. --- Barrett Esophagus. --- Esophagus ǂx abnormalities. --- Precancerous Conditions. --- Precancerous conditions. --- Diseases. --- Barrett Esophagus --- Precancerous Conditions --- abnormalities --- Barrett Epithelium --- Barrett Metaplasia --- Barrett's Esophagus --- Barrett's Syndrome --- Barrett Syndrome --- Esophagus, Barrett --- Barrett Metaplasias --- Barretts Esophagus --- Barretts Syndrome --- Epithelium, Barrett --- Esophagus, Barrett's --- Metaplasia, Barrett --- Metaplasias, Barrett --- Abnormities and deformities

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Genomics technologies revolutionised biomedicine research, but the genome alone is not sufficient to capture biological complexity. Postgenomic methods, typically based on mass spectrometry, comprise the analysis of metabolites, lipids, and proteins and are an essential complement to genomics and transcriptomics. Multidimensional omics is becoming established to provide accurate and comprehensive state descriptions. This book covers the latest methodological developments for, and applications of integrative multi-omics in biomedical research.

target identification --- target validation --- label-free method for drugs --- anti-angiogenesis --- mechanism of action --- receptor tyrosine kinases --- curcumin --- natural products --- lipid --- lipidomics --- cardiac metaplasia --- Barrett’s esophagus --- esophageal adenocarcinoma --- microbiota --- DNA sensing --- IFI16 --- cGAS --- innate immunity --- protein interactions --- virus–host interactions --- post-translational modifications --- mass spectrometry --- proteomics --- transcriptomics --- multi-omics --- multi-omics analysis --- study design --- bioinformatics --- machine learning --- analysis flow --- metabolomics --- planned myocardial infarction (PMI) --- myocardial infarction (MI) --- exercise --- heart --- cheminformatics --- batch variations --- eicosanoids --- fetal calf serum --- peroxisomes --- host-pathogen interactions --- secretome --- macrophages --- acute myeloid leukemia --- HL-60 cell line --- ATRA --- induced differentiation --- transcriptome --- proteome --- transcription factors --- key molecules --- regulatory pathway modelling --- SRM --- endometriosis --- inflammation --- n/a --- Barrett's esophagus --- virus-host interactions

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Recent decades have seen remarkable advances in the treatment of upper gastrointestinal malignancies, i.e., adenocarcinoma and squamous cell carcinoma as well as gastrointestinal stromal and other rare tumors of the esophagus and stomach. While, historically, surgical resection has been the sole treatment for these tumors, multimodal therapies have meanwhile proven their efficacy. At present, pre- and postoperative chemotherapy and radiotherapy, targeted drug therapy, and stage-specific surgical approaches are all indispensable cornerstones of an individualized treatment for upper gastrointestinal malignancies. With such multimodal treatment, better outcomes comprising improved quality of life and prolonged survival have been achieved for patients. However, for many tumor entities and stages, the ideal combination and sequence of treatments is still being evaluated in clinical trials. Moreover, the value of novel approaches such as immunotherapy or robotic surgery remains a matter of research. In this Special Issue of Cancers, up-to-date original research, short communications, and comprehensive review articles on all modalities playing a role in the treatment of upper gastrointestinal malignancies have been published.

Public health & preventive medicine --- gastric cancer --- gastrectomy --- complications --- outcome --- survival --- lymph node ratio --- neoadjuvant chemotherapy --- conversion surgery --- cancer dormancy --- nuclear receptor NR2F1 --- clinical pathways --- gastric surgery --- oncological gastrectomy --- quality of care --- outcomes --- standardization --- adjuvant therapy --- gastrointestinal tract --- genetic diagnosis --- radiosensitivity --- mortality --- failure to rescue --- immunotherapy --- genetics --- esophageal cancer --- multidisciplinary --- gastric/gastroesophageal cancer --- perioperative chemotherapy --- overall survival --- relapse-free survival --- skeletal muscle index --- esophagectomy --- nutritional status --- sarcopenia --- esophageal anastomosis --- minimally invasive surgery --- induction chemotherapy --- chemo-radiotherapy --- neoadjuvant treatment --- esophageal squamous cell carcinoma --- multimodal treatment --- neoadjuvant chemoradiotherapy --- definitive chemoradiotherapy --- Lauren histotype --- gastrointestinal stromal tumor --- neuroendocrine tumor --- MALT lymphoma --- mucosal resection --- submucosal dissection --- GIST --- stomach --- neoadjuvant therapy --- imatinib --- organ preservation --- squamous cell esophageal cancer --- gastro-esophageal reflux disease --- Barrett’s esophagus --- early adenocarcinoma of esophagus --- endoscopic submucosal dissection --- endoscopic mucosal resection --- n/a --- Barrett's esophagus

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Recent decades have seen remarkable advances in the treatment of upper gastrointestinal malignancies, i.e., adenocarcinoma and squamous cell carcinoma as well as gastrointestinal stromal and other rare tumors of the esophagus and stomach. While, historically, surgical resection has been the sole treatment for these tumors, multimodal therapies have meanwhile proven their efficacy. At present, pre- and postoperative chemotherapy and radiotherapy, targeted drug therapy, and stage-specific surgical approaches are all indispensable cornerstones of an individualized treatment for upper gastrointestinal malignancies. With such multimodal treatment, better outcomes comprising improved quality of life and prolonged survival have been achieved for patients. However, for many tumor entities and stages, the ideal combination and sequence of treatments is still being evaluated in clinical trials. Moreover, the value of novel approaches such as immunotherapy or robotic surgery remains a matter of research. In this Special Issue of Cancers, up-to-date original research, short communications, and comprehensive review articles on all modalities playing a role in the treatment of upper gastrointestinal malignancies have been published.

Public health & preventive medicine --- gastric cancer --- gastrectomy --- complications --- outcome --- survival --- lymph node ratio --- neoadjuvant chemotherapy --- conversion surgery --- cancer dormancy --- nuclear receptor NR2F1 --- clinical pathways --- gastric surgery --- oncological gastrectomy --- quality of care --- outcomes --- standardization --- adjuvant therapy --- gastrointestinal tract --- genetic diagnosis --- radiosensitivity --- mortality --- failure to rescue --- immunotherapy --- genetics --- esophageal cancer --- multidisciplinary --- gastric/gastroesophageal cancer --- perioperative chemotherapy --- overall survival --- relapse-free survival --- skeletal muscle index --- esophagectomy --- nutritional status --- sarcopenia --- esophageal anastomosis --- minimally invasive surgery --- induction chemotherapy --- chemo-radiotherapy --- neoadjuvant treatment --- esophageal squamous cell carcinoma --- multimodal treatment --- neoadjuvant chemoradiotherapy --- definitive chemoradiotherapy --- Lauren histotype --- gastrointestinal stromal tumor --- neuroendocrine tumor --- MALT lymphoma --- mucosal resection --- submucosal dissection --- GIST --- stomach --- neoadjuvant therapy --- imatinib --- organ preservation --- squamous cell esophageal cancer --- gastro-esophageal reflux disease --- Barrett's esophagus --- early adenocarcinoma of esophagus --- endoscopic submucosal dissection --- endoscopic mucosal resection --- gastric cancer --- gastrectomy --- complications --- outcome --- survival --- lymph node ratio --- neoadjuvant chemotherapy --- conversion surgery --- cancer dormancy --- nuclear receptor NR2F1 --- clinical pathways --- gastric surgery --- oncological gastrectomy --- quality of care --- outcomes --- standardization --- adjuvant therapy --- gastrointestinal tract --- genetic diagnosis --- radiosensitivity --- mortality --- failure to rescue --- immunotherapy --- genetics --- esophageal cancer --- multidisciplinary --- gastric/gastroesophageal cancer --- perioperative chemotherapy --- overall survival --- relapse-free survival --- skeletal muscle index --- esophagectomy --- nutritional status --- sarcopenia --- esophageal anastomosis --- minimally invasive surgery --- induction chemotherapy --- chemo-radiotherapy --- neoadjuvant treatment --- esophageal squamous cell carcinoma --- multimodal treatment --- neoadjuvant chemoradiotherapy --- definitive chemoradiotherapy --- Lauren histotype --- gastrointestinal stromal tumor --- neuroendocrine tumor --- MALT lymphoma --- mucosal resection --- submucosal dissection --- GIST --- stomach --- neoadjuvant therapy --- imatinib --- organ preservation --- squamous cell esophageal cancer --- gastro-esophageal reflux disease --- Barrett's esophagus --- early adenocarcinoma of esophagus --- endoscopic submucosal dissection --- endoscopic mucosal resection

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Endoscopic Therapy is emerging as the preferred therapy for early neoplasia in Barrett's Esophagus. This volume provides the key decision making factors in determining endoscopic therapy for an individual patient. All current techniques and complications of ET are provided including, photodynamic therapy (PDT), APC, multipolar electrocoagulation (MPEC), RF, ER, and cryotherapy. Each technique includes "how to highlights", high quality color endoscopic images, line drawings and diagrams. Endoscopic imaging modalities to detect dysplasia, decision making in the clinical arena and cost-effectiveness of ablation are some of the additional topics discussed in this highly practical volume. Written by experts in the field of endoscopic therapy, this text educates GI practitioners and researchers about this under-utilized approach to the treatment of Barrett’s Esophagus.

Endoscopic surgery. --- Endoscopy. --- Esophagus. --- Esophagus --- Endoscopy --- Endoscopic surgery --- Esophagoscopy --- Barrett Esophagus --- Methods --- Esophageal Neoplasms --- Gastrointestinal Neoplasms --- Endoscopy, Gastrointestinal --- Head and Neck Neoplasms --- Investigative Techniques --- Digestive System Abnormalities --- Esophageal Diseases --- Digestive System Neoplasms --- Gastrointestinal Diseases --- Endoscopy, Digestive System --- Digestive System Diseases --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Neoplasms by Site --- Diagnostic Techniques, Digestive System --- Diseases --- Digestive System Surgical Procedures --- Neoplasms --- Surgical Procedures, Operative --- Surgical Procedures, Minimally Invasive --- Diagnostic Techniques, Surgical --- Diagnostic Techniques and Procedures --- Diagnosis --- Oncology --- Gastroenterology --- Medicine --- Health & Biological Sciences --- Barrett's esophagus --- Treatment. --- Cancer. --- Barrett epithelium --- Barrett esophagus --- Barrett syndrome --- Barrett's epithelium --- Barrett's syndrome --- Epithelium, Barrett's --- Esophagus, Barrett's --- Medicine. --- Gastroenterology. --- Respiratory organs --- Minimally invasive surgery. --- Medicine & Public Health. --- Pneumology/Respiratory System. --- Minimally Invasive Surgery. --- Diseases. --- Abnormalities --- Precancerous conditions --- Pneumology. --- Endosurgery --- Minimal access surgery --- Minimally invasive surgery --- MIS (Minimally invasive surgery) --- Operative endoscopy --- Surgical endoscopy --- Microsurgery --- Surgery, Operative --- Internal medicine --- Digestive organs --- Gastroenterology . --- Respiratory organs—Diseases.